Literature DB >> 16558020

Immunogenicity of purified venezuelan equine encephalitis virus inactivated by ionizing radiation.

J Gruber1.   

Abstract

Purified and concentrated Venezuelan equine encephalitis (VEE) virus derived from tissue cultures, rendered noninfectious by ionizing radiation with retention of in vitro serological activity, also retained a high level of immunogenicity. In mice, fluid vaccines afforded excellent protection against lethal challenge with homologous Trinidad strain VEE virus. A direct relationship was observed between concentration of vaccine or number of injections and survival. One intraperitoneal inoculation of undiluted vaccine protected essentially all mice challenged 21 days later with 100,000 mouse intraperitoneal LD(50) of virus. Similarly, mice receiving three injections of vaccines diluted 1:100 were completely protected. Noninfectious VEE virus preparations combined with adjuvant 65, a nontoxic metabolizable vehicle, were likewise very effective in protecting mice immunized intraperitoneally or subcutaneously against lethal challenge. Guinea pigs immunized subcutaneously with adjuvant-combined vaccine survived lethal challenge of 1,000,000 guinea pig intraperitoneal LD(50).

Entities:  

Year:  1971        PMID: 16558020      PMCID: PMC416199          DOI: 10.1128/iai.3.4.574-579.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.

Authors:  D H CLARKE; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1958-09       Impact factor: 2.345

3.  Venezulean equine encephalomyelitis; laboratory aspects of fourteen human cases following vaccination and attempts to isolate the virus from the vaccine.

Authors:  D G SMITH; H K MAMAY; R G MARSHALL; J C WAGNER
Journal:  Am J Hyg       Date:  1956-03

4.  Immunization of laboratory workers with purified Venezuelan equine encephalomyelitis vaccine.

Authors:  R RANDALL; F D MAURER; J E SMADEL
Journal:  J Immunol       Date:  1949-11       Impact factor: 5.422

5.  Inactivation of Venezuelan Equine Encephalomyelitis Virus by gamma-Radiation.

Authors:  M Reitman; H R Tribble
Journal:  Appl Microbiol       Date:  1967-11

Review 6.  Critical appraisal of emulsified oil adjuvants applied to viral vaccines.

Authors:  M R Hilleman
Journal:  Prog Med Virol       Date:  1966

7.  Live, attenuated Venezuelan equine encephalomyelitis virus vaccine. I. Clinical effects in man.

Authors:  A C Alevizatos; R W McKinney; R D Feigin
Journal:  Am J Trop Med Hyg       Date:  1967-11       Impact factor: 2.345

8.  Gamma-irradiated Venezuelan equine encephalitis vaccines.

Authors:  M Reitman; H R Tribble; L Green
Journal:  Appl Microbiol       Date:  1970-05

9.  Purification, concentration, and inactivation of Venezuelan equine encephalitis virus.

Authors:  J Gruber
Journal:  Appl Microbiol       Date:  1970-09
  9 in total
  6 in total

1.  Formalin-inactivated Venezuelan equine encephalomyelitis (Trinidad strain) vaccine produced in rolling-bottle cultures of chicken embryo cells.

Authors:  F E Cole; S W May; D M Robinson
Journal:  Appl Microbiol       Date:  1973-02

2.  Immunization of mice against encephalomyocarditis virus. II. Intraperitoneal and respiratory immunization with ultraviolet-inactivated vaccine: effect of Bordetella pertussis extract on the immune response.

Authors:  W J Bogaerts
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

3.  A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV).

Authors:  Donald L Fine; Erin Jenkins; Shannon S Martin; Pamela Glass; Michael D Parker; Brad Grimm
Journal:  J Virol Methods       Date:  2009-11-10       Impact factor: 2.014

4.  Gamma ray-induced small plaque mutants of western equine encephalitis virus.

Authors:  B Simizu; S Yamazaki; K Suzuki; T Terasima
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

5.  Immunogenicity of purified, inactivated chikungunya virus in monkeys.

Authors:  E Nakao; S Hotta
Journal:  Bull World Health Organ       Date:  1973-05       Impact factor: 9.408

6.  Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB.

Authors:  Shannon S Martin; Russell R Bakken; Cathleen M Lind; Patricia Garcia; Erin Jenkins; Pamela J Glass; Michael D Parker; Mary Kate Hart; Donald L Fine
Journal:  Vaccine       Date:  2009-11-13       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.